Home»Exposition»Global $41 Bn Respiratory Drugs Market to 2023 – Leading Players are GSK, AstraZeneca and Boehringer Ingelheim

Global $41 Bn Respiratory Drugs Market to 2023 – Leading Players are GSK, AstraZeneca and Boehringer Ingelheim

0
Shares
Pinterest Google+
Research and Markets Logo

DUBLIN, October 12, 2017 /PRNewswire/ —
The “Global Respiratory Drugs Market to 2023 – A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers” report has…

Previous post

Global Cancer Immunotherapies Markets, 2017 - Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation

Next post

$25 Billion Global Personal Care Product Contract Manufacturing Market to 2025